Cited by 5,699Cardiovascular Function and Risk FactorsBlood Pressure and Hypertension StudiesCardiovascular Effects of Exercise

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study

Open access

Levy, Daniel, Garrison, Robert J., Savage, Daniel D., Kannel, William B., Castelli, William P.·1990·New England Journal of Medicine

DOI 10.1056/nejm199005313222203

Open this paper in CoChat — free account Open PDF

Abstract

A pattern of left ventricular hypertrophy evident on the electrocardiogram is a harbinger of morbidity and mortality from cardiovascular disease. Echocardiography permits the noninvasive determination of left ventricular mass and the examination of its role as a precursor of morbidity and mortality. We examined the relation of left ventricular mass to the incidence of cardiovascular disease, mortality from cardiovascular disease, and mortality from all causes in 3220 subjects enrolled in the Framingham Heart Study who were 40 years of age or older and free of clinically apparent cardiovascular disease, in whom left ventricular mass was determined echocardiographically. During a four-year follow-up period, there were 208 incident cardiovascular events, 37 deaths from cardiovascular disease, and 124 deaths from all causes. Left ventricular mass, determined echocardiographically, was associated with all outcome events. This relation persisted after we adjusted for age, diastolic blood pressure, pulse pressure, treatment for hypertension, cigarette smoking, diabetes, obesity, the ratio of total cholesterol to high-density lipoprotein cholesterol, and electrocardiographic evidence of left ventricular hypertrophy. In men, the risk factor-adjusted relative risk of cardiovascular disease was 1.49 for each increment of 50 g per meter in left ventricular mass corrected for the subject's height (95 percent confidence interval, 1.20 to 1.85); in women, it was 1.57 (95 percent confidence interval, 1.20 to 2.04). Left ventricular mass (corrected for height) was also associated with the incidence of death from cardiovascular disease (relative risk, 1.73 [95 percent confidence interval, 1.19 to 2.52] in men and 2.12 [95 percent confidence interval, 1.28 to 3.49] in women). Left ventricular mass (corrected for height) was associated with death from all causes (relative risk, 1.49 [95 percent confidence interval, 1.14 to 1.94] in men and 2.01 [95 percent confidence interval, 1.44 to 2.81] in women). We conclude that the estimation of left ventricular mass by echocardiography offers prognostic information beyond that provided by the evaluation of traditional cardiovascular risk factors. An increase in left ventricular mass predicts a higher incidence of clinical events, including death, attributable to cardiovascular disease.

Integrity signals

Registry

Crossref · 10.1056/nejm199005313222203

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
Devereux, R. B., Alonso, D. R., Lutas, E. M., Gottlieb, G. J., Campo, E., Sachs, I., & Reichek, N. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90771-x · Cited by 6,226
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.
Devereux, R. B., & Reichek, N. (1977) · Circulation · doi:10.1161/01.cir.55.4.613 · Cited by 4,499
Epidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148
Value of Echocardiographic Measurement of Left Ventricular Mass in Predicting Cardiovascular Morbid Events in Hypertensive Men
Casale, P. N., Devereux, R. B., Milner, M. R., Zullo, G., Harshfield, G. A., Pickering, T. G., & LARAGH, J. H. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-2-173 · Cited by 1,079
Echocardiographically Detected Left Ventricular Hypertrophy: Prevalence and Risk Factors
Levy, D. A., Anderson, K. M., SAVAGE, D. D., Kannel, W. B., Christiansen, J. C., & Castelli, W. P. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-1-7 · Cited by 819
Echocardiographic criteria for left ventricular hypertrophy: The Framingham heart study
Levy, D. A., Savage, D. D., Garrison, R. J., Anderson, K. M., Kannel, W. B., & Castelli, W. P. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91133-7 · Cited by 798
Left Ventricular Mass and Incidence of Coronary Heart Disease in an Elderly Cohort
Levy, D. A., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-2-101 · Cited by 700
Electrocardiographic Left Ventricular Hypertrophy and Risk of Coronary Heart Disease
Kannel, W. B., Gordon, T., Castelli, W. P., & MARGOLIS, J. R. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-72-6-813 · Cited by 638
Ventricular Arrhythmias in Patients with Hypertensive Left Ventricular Hypertrophy
McLenachan, J. M., Henderson, E., Morris, K. I., & Dargie, H. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709243171302 · Cited by 576

Show all 28 references

Research works printed but not linked: 2

Levy, 1987, Circulation, 76, IV-143
Marcus, 1987, Circulation, 75, I-19

Sorted by citations

Items 201–300 of 1,020

Cardiac and Arterial Target Organ Damage in Adults with Elevated Ambulatory and Normal Office Blood Pressure
Liu, J. E., Roman, M. J., Pini, R., Schwartz, J. E., Pickering, T. G., & Devereux, R. B. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-8-199910190-00003 · Cited by 353
Diabetic cardiomyopathy: mechanisms, diagnosis and treatment
Hayat, S. A., Patel, B., Khattar, R. S., & Malik, R. A. (2004) · Clinical Science · doi:10.1042/cs20040057 · Cited by 353
Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion
Ashrafian, H., Redwood, C. S., Blair, E. M., & Watkins, H. C. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00081-7 · Cited by 351
Sympathetic nervous activation in obesity and the metabolic syndrome—Causes, consequences and therapeutic implications
Lambert, G. W., Straznicky, N. E., Lambert, É., Dixon, J. B., & Schlaich, M. P. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.02.002 · Cited by 352
Guidelines for the management of arterial hypertension
van de Borne, P. (2014) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · doi:10.2143/ac.69.1.3011345 · Cited by 349
H 2 S Protects Against Pressure Overload–Induced Heart Failure via Upregulation of Endothelial Nitric Oxide Synthase
Kondo, K., Bhushan, S., King, A. L., Prabhu, S. D., Hamid, T., Koenig, S. C., Murohara, T., Predmore, B. L., Gojon, G., Gojon, G., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000855 · Cited by 344
Tumor Necrosis Factor-α Mediates Cardiac Remodeling and Ventricular Dysfunction After Pressure Overload State
Sun, M., Chen, M., Dawood, F., Zurawska, U., Li, J. Y., Parker, T., Kassiri, Z., Kirshenbaum, L. A., Arnold, M., Khokha, R., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.643585 · Cited by 383
Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I
Kedar, V., McDonough, H., Arya, R., Li, H., Rockman, H. A., & Patterson, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404341102 · Cited by 358
Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study11The data reported here were supplied by the United States Renal Data System. Interpretation of these data is the responsibility of the authors, and in no way should be seen as an official policy or interpretation of the U.S. government.
Foley, R. N., Herzog, C. A., & Collins, A. J. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00636.x · Cited by 345
Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years
Drazner, M. H., Rame, J. E., Marino, E. K., Gottdiener, J. S., Kitzman, D. W., Gardin, J. M., Manolio, T. A., Dries, D. L., & Siscovick, D. S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.11.064 · Cited by 342
Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
Mirza, M. A. I., Larsson, A. O., Melhus, H., Lind, L., & Larsson, T. E. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.013 · Cited by 343
Effects of isolated obesity on systolic and diastolic left ventricular function
Pascual, M., Pascual, D. A., Soria, F., Vicente, T., Hernández, A. M., Tébar, F. J., & Valdés, M. (2003) · Heart · doi:10.1136/heart.89.10.1152 · Cited by 336
Effect of Type 2 Diabetes Mellitus on Left Ventricular Geometry and Systolic Function in Hypertensive Subjects: Hypertension Genetic Epidemiology Network (HyperGEN) Study
Palmieri, V., Bella, J. N., Arnett, D. K., Liu, J. E., Oberman, A., Schuck, M.-Y., Kitzman, D. W., Hopkins, P. N., Morgan, D., Rao, D. C., et al. (2001) · Circulation · doi:10.1161/01.cir.103.1.102 · Cited by 339
Cardiovascular reactivity in cardiovascular disease: “Once more unto the breach”
Manuck, S. B. (1994) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm0101_2 · Cited by 339
Calcium Signaling in Cardiac MyocytesPreprint
Fearnley, C. J., Roderick, H. L., & Bootman, M. D. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004242 · Cited by 339
Left ventricular hypertrophy and hypertension
Yildiz, M., Oktay, A. A., Stewart, M. H., Milani, R. V., Ventura, H. O., & Lavie, C. J. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.11.009 · Cited by 345
Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload
Koitabashi, N., Danner, T., Zaiman, A., Pinto, Y. M., Rowell, J., Mankowski, J. L., Zhang, D., Nakamura, T., Takimoto, E., & Kass, D. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44824 · Cited by 335
Echocardiographic and Electrocardiographic Diagnoses of Left Ventricular Hypertrophy Predict Mortality Independently of Each Other in a Population of Elderly Men
Sundström, J., Lind, L., Ärnlöv, J., Zethelius, B., Andrén, B., & Lithell, H. (2001) · Circulation · doi:10.1161/01.cir.103.19.2346 · Cited by 335
Ambulatory Blood Pressure Monitoring and Organ Damage
Mancia, G., & Parati, G. (2000) · Hypertension · doi:10.1161/01.hyp.36.5.894 · Cited by 335
Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade.
London, G. M., Pannier, B., Guérin, A. P., Marchais, S. J., Safar, M. E., & Cuche, J. L. (1994) · Circulation · doi:10.1161/01.cir.90.6.2786 · Cited by 334
Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling
Braz, J. C., Bueno, O. F., Liang, Q., Wilkins, B. J., Dai, Y., Parsons, S. A., Braunwart, J., Glascock, B. J., Klevitsky, R., Kimball, T. F., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17295 · Cited by 332
Relationship of Echocardiographic Z Scores Adjusted for Body Surface Area to Age, Sex, Race, and Ethnicity
Lopez, L., Colan, S. D., Stylianou, M. P., Granger, S., Trachtenberg, F. L., Frommelt, P. C., Pearson, G. D., Camarda, J. A., Cnota, J. F., Cohen, M. S., et al. (2017) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.117.006979 · Cited by 333
Changes in Left Ventricular Anatomy and Function in Hypertension and Primary Aldosteronism
Rossi, G. P., Sacchetto, A., Visentin, P., Canali, C., Graniero, G. R., Palatini, P., & Pessina, A. C. (1996) · Hypertension · doi:10.1161/01.hyp.27.5.1039 · Cited by 325
The Relative Effects of Left Ventricular Hypertrophy, Coronary Artery Disease, and Ventricular Dysfunction on Survival Among Black Adults
Liao, Y. (1995) · JAMA · doi:10.1001/jama.1995.03520440046035 · Cited by 325
Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin
Connors, L. H., Sam, F., Skinner, M. M., Salinaro, F., Sun, F. X., Ruberg, F. L., Berk, J. L., & Seldin, D. C. (2015) · Circulation · doi:10.1161/circulationaha.115.018852 · Cited by 325
Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study
Manyari, D. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199012133232413 · Cited by 325
Comparison of Five Antihypertensive Monotherapies and Placebo for Change in Left Ventricular Mass in Patients Receiving Nutritional-Hygienic Therapy in the Treatment of Mild Hypertension Study (TOMHS)
Liebson, P. R., Grandits, G., DIANZUMBA, S. B., Prineas, R. J., Grimm, R. H., Neaton, J. D., & Stamler, J. (1995) · Circulation · doi:10.1161/01.cir.91.3.698 · Cited by 322
Left Ventricular Hypertrophy Is More Prevalent in Blacks Than Whites in the General Population
Drazner, M. H., Dries, D. L., Peshock, R. M., Cooper, R., Klassen, C., Kazi, F., Willett, D. L., & Victor, R. G. (2005) · Hypertension · doi:10.1161/01.hyp.0000169972.96201.8e · Cited by 318
The roles of gender, the menopause and hormone replacement on cardiovascular function
Hayward, C. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00005-5 · Cited by 323
Mechanical Stretch Activates the JAK/STAT Pathway in Rat Cardiomyocytes
Pan, J., Fukuda, K., Saito, M., Matsuzaki, J., Kodama, H., Sano, M., Takahashi, T., Katō, T., & Ogawa, S. (1999) · Circulation Research · doi:10.1161/01.res.84.10.1127 · Cited by 313
Cardiac hypertrophy is not a required compensatory response to short-term pressure overload
Hill, J. A., Karimi, M., Kutschke, W., Davisson, R. L., Zimmerman, K., Wang, Z., Kerber, R. E., & Weiss, R. M. (2000) · Circulation · doi:10.1161/01.cir.101.24.2863 · Cited by 309
Ventricular Expression of a MLC-2v-ras Fusion Gene Induces Cardiac Hypertrophy and Selective Diastolic Dysfunction in Transgenic Mice
Hunter, J. J., Tanaka, N., Rockman, H. A., Ross, J., & Chien, K. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.23173 · Cited by 312
Remodeling and reparation of the cardiovascular system
Weber, K. T., Anversa, P., Armstrong, P. W., Brilla, C. G., Burnett, J. C., Cruickshank, J. M., Devereux, R. B., Giles, T. D., Korsgaard, N., Leier, C. V., et al. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90130-f · Cited by 312
Molecular regulation of cardiac hypertrophy
Barry, S. P., Davidson, S. M., & Townsend, P. A. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.02.020 · Cited by 318
Age-Related Changes in Aortic Arch Geometry
Redheuil, A. B., Yu, W., Mousseaux, É., Harouni, A. A., Kachenoura, N., Wu, C. O., Bluemke, D. A., & Lima, J. A. C. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.012 · Cited by 309
Augmentation index as a measure of peripheral vascular disease state
Nichols, W. W., & Singh, B. M. (2002) · Current Opinion in Cardiology · doi:10.1097/00001573-200209000-00016 · Cited by 309
70-year legacy of the Framingham Heart Study
Andersson, C., Johnson, A. D., Benjamin, E. J., Levy, D., & Vasan, R. S. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0202-5 · Cited by 305
Self-citation
Angiotensin II Partly Mediates Mechanical Stress–Induced Cardiac Hypertrophy
Yamazaki, T., Komuro, I., Kudoh, S., Zou, Y., Shiojima, I., Mizuno, T., Takano, H., Hiroi, Y., Ueki, K., Tobe, K., et al. (1995) · Circulation Research · doi:10.1161/01.res.77.2.258 · Cited by 304
Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease
Daniels, S. R., Kimball, T. R., Morrison, J. A., Khoury, P. R., & Meyer, R. A. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80200-8 · Cited by 303
Reliability of echocardiographic assessment of left ventricular structure and function
Palmieri, V., Dahlöf, B., DeQuattro, V. L., Sharpe, N., Bella, J. N., SIMONE, G. D., Paranicas, M., Fishman, D., & Devereux, R. B. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00396-4 · Cited by 303
Relationship of Cardiovascular Risk Factors to Echocardiographic Left Ventricular Mass in Healthy Young Black and White Adult Men and Women
Gardin, J. M., Wagenknecht, L. E., Anton‐Culver, H., Flack, J. M., Gidding, S. S., Kurosaki, T., Wong, N. D., & Manolio, T. A. (1995) · Circulation · doi:10.1161/01.cir.92.3.380 · Cited by 302
Effect of the Direct Renin Inhibitor Aliskiren, the Angiotensin Receptor Blocker Losartan, or Both on Left Ventricular Mass in Patients With Hypertension and Left Ventricular Hypertrophy
Solomon, S. D., Appelbaum, E. A., Manning, W. J., Verma, A. K., Berglund, T., Lukashevich, V., Papst, C. C., Smith, B. A., & Dahlöf, B. (2009) · Circulation · doi:10.1161/circulationaha.108.826214 · Cited by 301
Protective effects of exercise and phosphoinositide 3-kinase(p110α) signaling in dilated and hypertrophic cardiomyopathy
McMullen, J. R., Amirahmadi, F., Woodcock, E. A., Schinke-Braun, M., Bouwman, R. D., Hewitt, K. A., Mollica, J. P., Zhang, L., Zhang, Y., Shioi, T., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606663104 · Cited by 303
Assessment of Left Ventricular Mass by Cardiovascular Magnetic Resonance
Myerson, S. G., Bellenger, N. G., & Pennell, D. J. (2002) · Hypertension · doi:10.1161/hy0302.104674 · Cited by 298
Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy
Yussman, M. G., Toyokawa, T., Odley, A. M., Lynch, R. A., Wu, G., Colbert, M. C., Aronow, B. J., Lorenz, J. N., & Dorn, G. W. (2002) · Nature Medicine · doi:10.1038/nm719 · Cited by 300
Molecular targets and regulators of cardiac hypertrophy
Rohini, A., Agrawal, N. K., Koyani, C. N., & Singh, R. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.11.012 · Cited by 304
Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy
Taigen, T. L., Windt, L. J. D., Lim, H. W., & Molkentin, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1196 · Cited by 294
Characteristics of 9194 Patients With Left Ventricular Hypertrophy
Dahlöf, B., Devereux, R. B., Julius, S., Kjeldsen, S. E., Beevers, G., Fairé, U. D., Fyhrquist, F., Hedner, T., Ibsen, H., Kristianson, K. J., et al. (1998) · Hypertension · doi:10.1161/01.hyp.32.6.989 · Cited by 294
Left Ventricular Hypertrophy as an Independent Predictor of Acute Cerebrovascular Events in Essential Hypertension
Verdecchia, P., Porcellati, C., Reboldi, G., Gattobigio, R., Borgioni, C., Pearson, T. A., & Ambrosio, G. (2001) · Circulation · doi:10.1161/hc4201.097944 · Cited by 293
Traditional Cardiovascular Risk Factors in Relation to Left Ventricular Mass, Volume, and Systolic Function by Cardiac Magnetic Resonance Imaging
Heckbert, S. R., Post, W., Pearson, G. D. N., Arnett, D. K., Gomes, A. S., Jerosch-Herold, M., Hundley, W. G., Lima, J. A., & Bluemke, D. A. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.072 · Cited by 292
Prognostic Impact of the Indexation of Left Ventricular Mass in Patients Undergoing Dialysis
Zoccali, C., Benedetto, F. A., Mallamaci, F., Tripepi, G. L., Giacone, G., Cataliotti, A., Seminara, G., Stancanelli, B., & Malatino, L. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12122768 · Cited by 292
Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk?
Barton, D. A., Dawood, T., Lambert, E. A., Esler, M. D., Haikerwal, D., Brenchley, C., Socratous, F., Kaye, D. M., Schlaich, M. P., Hickie, I., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e32829baae7 · Cited by 291
Prognostic Implications of Left Ventricular Mass and Geometry Following Myocardial Infarction
Verma, A., Meris, A., Skali, H., Ghali, J. K., Arnold, J. M. O., Bourgoun, M., Velazquez, E. J., McMurray, J. J. V., Køber, L., Pfeffer, M. A., et al. (2008) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2008.05.012 · Cited by 291
The left atrium
Douglas, P. S. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00956-2 · Cited by 288
Benefits of Thyrotropin Suppression Versus the Risks of Adverse Effects in Differentiated Thyroid Cancer
Biondi, B., & Cooper, D. S. (2010) · Thyroid · doi:10.1089/thy.2009.0311 · Cited by 286
Canonical Transient Receptor Potential Channels Promote Cardiomyocyte Hypertrophy through Activation of Calcineurin Signaling
Bush, E. W., Hood, D. B., Papst, P. J., Chapo, J. A., Minobe, W. A., Bristow, M. R., Olson, E. N., & McKinsey, T. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605536200 · Cited by 285
Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans
Rossi, M. A. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816070-00018 · Cited by 285
Effect of Single-Drug Therapy on Reduction of Left Ventricular Mass in Mild to Moderate Hypertension
Gottdiener, J. S., Reda, D. J., Massie, B. M., Materson, B. J., Williams, D. W., & Anderson, R. J. (1997) · Circulation · doi:10.1161/01.cir.95.8.2007 · Cited by 284
Phenotyping Hypertrophy
Dorn, G. W., Robbins, J. M., & Sugden, P. H. (2003) · Circulation Research · doi:10.1161/01.res.0000077012.11088.bc · Cited by 272
Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy∗∗∗∗A list of participating hospitals, central agencies and personnel appears in reference 26.
Quiñones, M. A., Greenberg, B., Kopelen, H. A., Koilpillai, C. J., Limacher, M. C., Shindler, D. M., Shelton, B. J., & Weiner, D. H. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00511-8 · Cited by 280
Blood Pressure Variability and Organ Damage in a General Population
Sega, R., Corrao, G., Bombelli, M., Beltrame, L., Facchetti, R., Grassi, G. M., Ferrario, M., & Mancia, G. (2002) · Hypertension · doi:10.1161/hy0202.104376 · Cited by 276
Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events.
Verdecchia, P., Schillaci, G., Gatteschi, C., Zampi, I., Battistelli, M., Bartoccini, C., & Porcellati, C. (1993) · Circulation · doi:10.1161/01.cir.88.3.986 · Cited by 276
Mechanisms of cardiac dysfunction in obstructive sleep apnea
Baguet, J.-P., Barone‐Rochette, G., Tamisier, R., Levy, P. A., & Pépin, J. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.141 · Cited by 285
The Cardiovascular Risk of Young Women with Polycystic Ovary Syndrome: An Observational, Analytical, Prospective Case-Control Study
Orio, F., Palomba, S., Spinelli, L., Cascella, T., Tauchmanovà, L., Zullo, F., Lombardi, G., & Colao, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032049 · Cited by 275
Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?
Urhausen, A. J. P., Albers, T., & Kindermann, W. (2004) · Heart · doi:10.1136/hrt.2003.015719 · Cited by 275
A population-based phenome-wide association study of cardiac and aortic structure and function
Bai, W., Suzuki, H., Huang, J. V., Francis, C., Wang, S., Tarroni, G., Guitton, F., Aung, N., Fung, K., Petersen, S. E., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1009-y · Cited by 266
European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)
Backer, G. D., Ambrosioni, E., Broch-Johnsen, K., Brotons, C., Cífková, R., Dallongeville, J., Ebrahim, S. B. J., Færgeman, O., Graham, I. D., Mancia, G., et al. (2003) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/00149831-200312001-00001 · Cited by 273
Effect of Lean Body Mass, Fat Mass, Blood Pressure, and Sexual Maturation on Left Ventricular Mass in Children and Adolescents
Daniels, S. R., Kimball, T. R., Morrison, J. A., Khoury, P. R., Witt, S. A., & Meyer, R. A. (1995) · Circulation · doi:10.1161/01.cir.92.11.3249 · Cited by 273
TRPC channels are necessary mediators of pathologic cardiac hypertrophy
Wu, X., Eder, P., Chang, B., & Molkentin, J. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001825107 · Cited by 273
Remodeling of the Left Ventricle in Primary Aldosteronism Due to Conn’s Adenoma
Rossi, G. P., Sacchetto, A., Pavan, E., Palatini, P., Graniero, G. R., Canali, C., & Pessina, A. C. (1997) · Circulation · doi:10.1161/01.cir.95.6.1471 · Cited by 273
Requirement of Rac1 in the development of cardiac hypertrophy
Satoh, M., Ogita, H., Takeshita, K., Mukai, Y., Kwiatkowski, D. J., & Liao, J. K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510444103 · Cited by 271
RETRACTED: miR-29b as a Therapeutic Agent for Angiotensin II-induced Cardiac Fibrosis by Targeting TGF-β/Smad3 signaling
Zhang, Y., Huang, X., Wei, L., Chung, A. C., Yu, C., & Lan, H.-Y. (2014) · Molecular Therapy · doi:10.1038/mt.2014.25 · Cited by 271
Retracted
Potassium channel down-regulation in heart failure
Näbauer, M. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00274-5 · Cited by 269
Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromso Study
Svartberg, J. B., von Mühlen, D. G., Schirmer, H., Barrett-Connor, E. L., Sundfjord, J., & Jorde, R. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500065 · Cited by 270
Mitochondria in cardiac hypertrophy and heart failure
Rosca, M. G., Tandler, B., & Hoppel, C. L. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.09.002 · Cited by 269
Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction
Perrino, C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25397 · Cited by 266
Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure
Hayashi, T., Suzuki, A., Shoji, T., Togawa, M., Okada, N., Tsubakihara, Y., Imai, E., & Hori, M. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70334-9 · Cited by 266
Thyroid hormone and blood pressure regulation
Danzi, S., & Klein, I. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0060-7 · Cited by 261
Fifty years of Framingham Study contributions to understanding hypertension
Kannel, W. B. (2000) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000949 · Cited by 263
BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure
Duan, Q., McMahon, S., Anand, P., Shah, H., Thomas, S., Salunga, H. T., Huang, Y., Zhang, R., Sahadevan, A., Lemieux, M. E., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah5084 · Cited by 262
Echocardiography-based left ventricular mass estimation. How should we define hypertrophy?
Foppa, M., Duncan, B. B., & Rohde, L. E. P. (2005) · Cardiovascular Ultrasound · doi:10.1186/1476-7120-3-17 · Cited by 269
Relationship Between Left Ventricular Geometry and Natriuretic Peptide Levels in Essential Hypertension
Nishikimi, T., Yoshihara, F., Morimoto, A., Ishikawa, K., Ishimitsu, T., Saito, Y., Kangawa, K., Matsuo, H., Omae, T., & Matsuoka, H. (1996) · Hypertension · doi:10.1161/01.hyp.28.1.22 · Cited by 261
The sympathetic nervous system and blood pressure in humans: implications for hypertension
Fisher, J. P., & Paton, J. F. R. (2011) · Journal of Human Hypertension · doi:10.1038/jhh.2011.66 · Cited by 264
Effect of body size, ponderosity, and blood pressure on left ventricular growth in children and young adults in the Bogalusa Heart Study
Urbina, E. M., Gidding, S. S., Bao, W., Pickoff, A. S., Berdusis, K., & Berenson, G. S. (1995) · Circulation · doi:10.1161/01.cir.91.9.2400 · Cited by 259
Sex, Age, and Disease Affect Echocardiographic Left Ventricular Mass and Systolic Function in the Free-Living Elderly
Gardin, J. M., Siscovick, D. S., Anton‐Culver, H., Lynch, J. C., Smith, V. E., Klopfenstein, H. S., Bommer, W. J., Fried, L. F., O’Leary, D. H., & Manolio, T. A. (1995) · Circulation · doi:10.1161/01.cir.91.6.1739 · Cited by 259
Autonomic imbalance, hypertension, and cardiovascular risk
Brook, R. H. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)00228-4 · Cited by 260
Pulse Pressure and Mortality in Older People
Glynn, R. J., Chae, C. U., Guralnik, J. M., Taylor, J. O., & Hennekens, C. H. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.18.2765 · Cited by 258
Regression of Electrocardiographic Left Ventricular Hypertrophy by Losartan Versus Atenolol
Okin, P. M., Devereux, R. B., Jern, S., Kjeldsen, S. E., Julius, S., Nieminen, M. S., Snapinn, S. M., Harris, K. E., Aurup, P., Edelman, J. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000083724.28630.c3 · Cited by 257
Cardiac Structure and Function and Prognosis in Heart Failure With Preserved Ejection Fraction
Shah, A. M., Claggett, B. L., Sweitzer, N. K., Shah, S. J., Anand, I. S., O’Meara, E., Desai, A. S., Heitner, J. F., Li, G., Fang, J. C.-T., et al. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001583 · Cited by 263
Peroxisome Proliferator-Activated Receptor γ Plays a Critical Role in Inhibition of Cardiac Hypertrophy In Vitro and In Vivo
Asakawa, M., Takano, H., Nagai, T., Uozumi, H., Hasegawa, H., Kubota, N., Saito, T., Masuda, Y., Kadowaki, T., & Komuro, I. (2002) · Circulation · doi:10.1161/hc1002.105225 · Cited by 253
Prognostic Value of a New Electrocardiographic Method for Diagnosis of Left Ventricular Hypertrophy in Essential Hypertension
Verdecchia, P., Schillaci, G., Borgioni, C., Ciucci, A., Gattobigio, R., Zampi, I., & Porcellati, C. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00493-2 · Cited by 254
Female sex and estrogen receptor-β attenuate cardiac remodeling and apoptosis in pressure overload
Fliegner, D., Schubert, C., Penkalla, A., Witt, H., Kararigas, G., Dworatzek, E., Staub, E., Martus, P., Ruíz, P., Kintscher, U., et al. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00825.2009 · Cited by 260
APJ acts as a dual receptor in cardiac hypertrophy
Scimia, M. C., Hurtado, C., Ray, S., Metzler, S. A., Wei, K., Wang, J., Woods, C. E., Purcell, N. H., Catalucci, D., Akasaka, T., et al. (2012) · Nature · doi:10.1038/nature11263 · Cited by 251
Inhibition of Hypertrophy Is a Good Therapeutic Strategy in Ventricular Pressure Overload
Schiattarella, G. G., & Hill, J. A. (2015) · Circulation · doi:10.1161/circulationaha.115.013894 · Cited by 255
Serial Change in Echocardiographic Parameters and Cardiac Failure in End-Stage Renal Disease
Foley, R. N., Parfrey, P. S., Kent, G. M., Harnett, J. D., Murray, D. C., & Barré, P. E. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v115912 · Cited by 250
Childhood obesity and its physical and psychological co-morbidities: A Systematic review of australian children and adolescents
Sanders, R. H., Han, A., Baker, J. S., & Cobley, S. (2015) · European Journal of Pediatrics · doi:10.1007/s00431-015-2551-3 · Cited by 250
Distribution and Categorization of Echocardiographic Measurements in Relation to Reference Limits: The Framingham Heart Study: Formulation of a Height- and Sex-Specific Classification and Its Prospective Validation
Vasan, R. S., Larson, M. G., Levy, D., Evans, J. C., & Benjamin, E. J. (1997) · Circulation · doi:10.1161/01.cir.96.6.1863 · Cited by 248
Self-citation
Sudden cardiac death. Support for a role of triggering in causation.
Willich, S. N., Maclure, M., Mittleman, M. A., Arntz, H. R., & Muller, J. E. (1993) · Circulation · doi:10.1161/01.cir.87.5.1442 · Cited by 246
Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo
Purcell, N. H., Wilkins, B. J., York, A. J., Saba-El-Leil, M. K., Meloche, S., Robbins, J. M., & Molkentin, J. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610906104 · Cited by 250
The Role of Hypertension in the Pathogenesis of Heart Failure
Vasan, R. S. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440150033003 · Cited by 255

Authors: Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P.
Affiliations: National Heart, Lung, and Blood Institute (US)
National Center for Health Statistics (US)
Boston University (US)
ORCID: Levy, Daniel
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1990-05-31
Volume: 322
Issue: 22
Pages: 1561-1566
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199005313222203
OpenAlex: W2334499091
Cited by: 5,699
References: 28
Citations by year: 2026: 77 · 2025: 76 · 2024: 85 · 2023: 100 · 2022: 117 · 2021: 124 · 2020: 156 · 2019: 142 · 2018: 134 · 2017: 170 · 2016: 189 · 2015: 211 · 2014: 215 · 2013: 199 · 2012: 215
FWCI: 76.54
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Keywords: left ventricular mass, left ventricular hypertrophy, cardiovascular disease incidence, cardiovascular mortality, all-cause mortality, echocardiography, cardiovascular risk factors, hypertension, sex differences, Framingham Heart Study
MeSH terms: Blood Pressure, Echocardiography, Female, Follow-Up Studies, Cardiomegaly, Humans, Lipids, Male, Middle Aged, Prognosis, Risk Factors, Smoking, Multivariate Analysis, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks